Synthesis and evaluation of tricyclic dipyrido diazepinone derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 17456044)

Published in Curr Top Med Chem on January 01, 2007

Authors

N R Thimmegowda1, K K Dharmappa, C S Ananda Kumar, M P Sadashiva, A D Sathish, B L Nanda, B S Vishwanath, K S Rangappa

Author Affiliations

1: Department of Studies in Chemistry, University of Mysore, Mysore-570 006, India.

Articles by these authors

Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies. Bioorg Med Chem Lett (2005) 1.37

Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy. J Phys Chem B (2007) 1.22

Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon (1987) 1.20

2-(4-Chloro-phen-yl)-6-methyl-4-(3-methyl-phen-yl)quinoline. Acta Crystallogr Sect E Struct Rep Online (2012) 1.18

1-Benzhydryl-4-(4-chloro-phenyl-sulfonyl)piperazine. Acta Crystallogr Sect E Struct Rep Online (2008) 1.15

PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants--a new role as anti-inflammatory molecule. Curr Top Med Chem (2007) 1.06

Enhancement in antimicrobial activity of 2-(phenyl)-3-(2-butyl-4-chloro-1H-imidazolyl)-5-butylate isoxazolidine. Bioorg Med Chem Lett (2005) 1.03

Solution-phase synthesis of novel delta2-isoxazoline libraries via 1,3-dipolar cycloaddition and their antifungal properties. Bioorg Med Chem (2003) 1.00

Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. Biochim Biophys Acta (1989) 0.97

Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. Eur J Med Chem (2008) 0.97

Hyaluronidase inhibitors: a biological and therapeutic perspective. Curr Med Chem (2009) 0.96

Procoagulant activity of Calotropis gigantea latex associated with fibrin(ogen)olytic activity. Toxicon (2005) 0.95

The anti-snake venom properties of Tamarindus indica (leguminosae) seed extract. Phytother Res (2006) 0.94

Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J Exp Med (1997) 0.94

2-(2-(2-Ethoxybenzoylamino)-4-chlorophenoxy)-N-(2-ethoxybenzoyl)benzamine inhibits EAT cell induced angiogenesis by down regulation of VEGF secretion. Bioorg Med Chem Lett (2007) 0.93

Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives. Bioorg Med Chem (2010) 0.91

Spectrophotometric methods for the determination of certain catecholamine derivatives in pharmaceutical preparations. Talanta (1998) 0.91

Annexin I modulates cell functions by controlling intracellular calcium release. FASEB J (1999) 0.89

In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor. Bioorg Med Chem (2007) 0.88

Extractive spectrophotometric methods for the assay of sildenafil citrate (Viagra) in pure form and in pharmaceutical formulations. Talanta (2002) 0.88

5-(Prop-2-yn-1-yl)-5H-dibenzo[b,f]azepine: ortho-rhom-bic polymorph. Acta Crystallogr Sect E Struct Rep Online (2012) 0.88

5-[(4-Benzyl-1H-1,2,3-triazol-1-yl)meth-yl]-5H-dibenzo[b,f]azepine. Acta Crystallogr Sect E Struct Rep Online (2013) 0.88

Stability indicating RP-LC determination of sildenafil citrate (Viagra) in pure form and in pharmaceutical samples. J Pharm Biomed Anal (2002) 0.87

Anticoagulant effect of Naja naja venom 5'nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acid. Toxicon (2006) 0.87

Topical application of serine proteases from Wrightia tinctoria R. Br. (Apocyanaceae) latex augments healing of experimentally induced excision wound in mice. J Ethnopharmacol (2013) 0.87

Chemistry and structural evaluation of different phospholipase A2 inhibitors in arachidonic acid pathway mediated inflammation and snake venom toxicity. Curr Top Med Chem (2007) 0.87

Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot. Biochimie (2006) 0.86

Hyaluronidase and protease activities from Indian snake venoms: neutralization by Mimosa pudica root extract. Fitoterapia (2004) 0.86

Specific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem (2008) 0.85

Novel delta2-isoxazolines as group II phospholipase A2 inhibitors. Bioorg Med Chem Lett (2004) 0.85

Thrombin like activity of Asclepias curassavica L. latex: action of cysteine proteases. J Ethnopharmacol (2009) 0.84

Spectrophotometric method for the determination of paracetamol and phenacetin. J Pharm Biomed Anal (1998) 0.84

Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology (1998) 0.83

Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats. Phytomedicine (2012) 0.83

A dietary colorant crocin mitigates arthritis and associated secondary complications by modulating cartilage deteriorating enzymes, inflammatory mediators and antioxidant status. Biochimie (2012) 0.83

Synthesis of 2-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells. Bioorg Med Chem (2009) 0.82

Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology. Arch Toxicol (2013) 0.81

Crystal structures of the free and anisic acid bound triple mutant of phospholipase A2. J Mol Biol (2003) 0.81

Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipases A2. Biochim Biophys Acta (1994) 0.81

Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorg Med Chem Lett (2007) 0.81

Cysteine proteases from the Asclepiadaceae plants latex exhibited thrombin and plasmin like activities. J Thromb Thrombolysis (2008) 0.81

Systemic pathological effects induced by cobra (Naja naja) venom from geographically distinct origins of Indian peninsula. Exp Toxicol Pathol (2009) 0.80

Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine. Bioorg Med Chem (2006) 0.80

Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Invest New Drugs (2008) 0.80

Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom. J Thromb Thrombolysis (2010) 0.79

Melatonin alleviates Echis carinatus venom-induced toxicities by modulating inflammatory mediators and oxidative stress. J Pineal Res (2014) 0.79

Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures. Bioorg Med Chem Lett (2004) 0.78

Differential action of proteases from Trimeresurus malabaricus, Naja naja and Daboia russellii venoms on hemostasis. Comp Biochem Physiol C Toxicol Pharmacol (2006) 0.78

Evaluation of in vivo wound-healing potential of 2-[4-(2,4-dimethoxy-benzoyl)-phenoxy]-1-[4-(3-piperidin-4-yl-propyl)-piperidin-1-yl]-ethanone derivatives. Eur J Med Chem (2009) 0.78

The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin. Ann Hematol (2010) 0.78

Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Agents Actions (1988) 0.78

Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: a SAR study. Invest New Drugs (2008) 0.78

Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule. Curr Top Med Chem (2007) 0.78

Synthesis, characterization, antimicrobial and single crystal X-ray crystallographic studies of some new sulfonyl, 4-chloro phenoxy benzene and dibenzoazepine substituted benzamides. Eur J Med Chem (2006) 0.78

Cyclocondensation of arylhydrazines with 1,3-bis(het)arylmonothio-1,3-diketones and 1,3-bis(het)aryl-3-(methylthio)-2-propenones: synthesis of 1-aryl-3,5-bis(het)arylpyrazoles with complementary regioselectivity. J Org Chem (2013) 0.77

Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activity. Mol Cell Biochem (2010) 0.77

Strong myotoxic activity of Trimeresurus malabaricus venom: role of metalloproteases. Mol Cell Biochem (2006) 0.77

Application of Azure C for the extractive spectrophotometric determination of microgram amounts of penicillin. J Pharmacol Methods (1985) 0.77

Characterization of major zinc containing myonecrotic and procoagulant metalloprotease 'malabarin' from non lethal trimeresurus malabaricus snake venom with thrombin like activity: its neutralization by chelating agents. Curr Top Med Chem (2011) 0.77

Local and systemic toxicity of Echis carinatus venom: neutralization by Cassia auriculata L. leaf methanol extract. J Nat Med (2014) 0.77

Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. Bioorg Med Chem (2009) 0.77

Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study. Invest New Drugs (2008) 0.77

Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study. Invest New Drugs (2008) 0.77

Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo. Endocrinology (1995) 0.76

Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors. Open Med Chem J (2007) 0.76

Effect of anticoagulants on the plasma hyaluronidase activities. J Clin Lab Anal (2009) 0.76

N-[4-Cyano-3-(trifluoro-meth-yl)phen-yl]-2-eth-oxy-benzamide. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75

N-[4-Cyano-3-(trifluoro-meth-yl)phen-yl]-2-meth-oxy-benzamide. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75

Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of tumor growth and tumor angiogenesis of mouse ehrlich ascites tumor in vivo. Med Chem (2008) 0.75

Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. Bioorg Med Chem (2008) 0.75

A triclinic polymorph of (E)-2-(4-iso-butyl-phen-yl)-N'-[1-(4-nitro-phen-yl)ethyl-idene]propano-hydrazide. Acta Crystallogr Sect E Struct Rep Online (2013) 0.75

7-Chloro-5-cyclo-propyl-9-methyl-5H-4,5,6,10-tetra-aza-dibenzo[a,d]cyclo-hepten-11(10H)-one. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75

4-[5-(4-Benzoyl-oxyphen-yl)-1,2,4-oxa-diazol-3-yl]phenyl benzoate. Acta Crystallogr Sect E Struct Rep Online (2013) 0.75

(2R*,4R*,7S*,10R*,12R*)-3,11,13,15-Tetra-oxa-penta-cyclo-[5.5.3.0(1,7).0(2,4).0(10,12)]penta-deca-5,8-dien-14-one. Acta Crystallogr Sect E Struct Rep Online (2013) 0.75

(2aR*,5S*,6aS*,8aS*,E)-Ethyl 5-hy-droxy-7,7,8a-trimethyl-8-oxo-2,2a,6,6a,7,8,8a,8b-octa-hydro-1H-penta-leno[1,6-bc]oxepine-4-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75

Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models. Bioorg Med Chem (2008) 0.75

Synthesis and characterization of nucleoside derivatives, n-(benzoyl)-n-(deoxyguanosin-8-yl)4-aminobiphenyl and n-(2'-deoxyguanosin-8-yl)4-aminobiphenyl via alpha-phenyl-n-(4-biphenyl)nitrone. Nucleosides Nucleotides Nucleic Acids (2002) 0.75

Synthesis and identification of a new class of (S)-2,6-diamino-4,5,6,7-tetrahydrobenzo[d]thiazole derivatives as potent antileukemic agents. Invest New Drugs (2009) 0.75

Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. Int J Mol Med (2005) 0.75

Synthesis and antimicrobial activity of 1-benzhydryl-sulfonyl-4-(3-(piperidin-4-yl) propyl)piperidine derivatives against pathogens of Lycopersicon esculentum: a structure-activity evaluation study. Arch Pharm Res (2009) 0.75

Synthesis and identification of a new class of antileukemic agents containing 2-(arylcarboxamide)-(S)-6-amino-4,5,6,7-tetrahydrobenzo[d]thiazole. Eur J Med Chem (2010) 0.75

Synthesis of 1-(4-methoxybenzyl)-3-cyclopropyl-1H-pyrazol-5-amine derivatives as antimicrobial agents. J Enzyme Inhib Med Chem (2010) 0.75

Dapsone and iminodibenzyl as novel reagents for the spectrophotometric determination of trace amounts of nitrite in water samples. Anal Sci (2001) 0.75

Malabarase, a serine protease with anticoagulant activity from Trimeresurus malabaricus venom. Comp Biochem Physiol B Biochem Mol Biol (2012) 0.75

Differences in phospholipase A2 activity between males and females and Asian Indians and Caucasians. Eur J Clin Invest (1996) 0.75

Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors. Bioorg Med Chem (2007) 0.75

Oxidimetric determination of amino acids and their metal complexes with organic monochloramines. Analyst (1986) 0.75

Synthesis and antimicrobial studies of novel 1-benzhydryl-piperazine sulfonamide and carboxamide derivatives. J Enzyme Inhib Med Chem (2008) 0.75

Synthesis and screening for acetylcholinesterase inhibitor activity of some novel 2-butyl-1,3-diaza-spiro[4,4]non-1-en-4-ones: derivatives of irbesartan key intermediate. Bioorg Med Chem (2007) 0.75